ALT

AS OF

Oct 22, 01:14 PM (EDT)

Price

$2.19

Change

-$0.04 (-1.79%)

Capitalization

433.77M

14 days until earnings call

Intraday BUY SELL Signals

OUR PRODUCTS

MOBILE APPS

GENERAL INFO

Help

+Compare

ALT

Stock ticker: NASDAQ

AS OF

Oct 22, 01:14 PM (EDT)

Price

$2.19

Change

-$0.04 (-1.79%)

Capitalization

433.77M

ALT

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Altimmune (ALT) Ownership - Who owns Altimmune?

Altimmune Inc is a late clinical-stage biopharmaceutical company developing therapies for patients with serious liver diseases... Show more

Industry: #Miscellaneous Commercial Services

Get AI intraday signals

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Profile

Industry

Miscellaneous Commercial Services

Address

910 Clopper Road

Phone

+1 240 654-1450

Employees

Web

https://www.altimmune.com

Details

Group

Domestic Stock Funds

GYRE vs NKTX: A Revenue-Generating Biotech Faces Off Against a Clinical-Stage Cell Therapy Developer

RCUS

Why Is Arcus Biosciences (RCUS) Stock Up +10.34% Today?

IOVA

Iovance Biotherapeutics (IOVA): Tracking Catalysts and Commercial Expansion in TIL Therapy

CGEM

CGEM vs RAPP: Cullinan Therapeutics and Rapport Therapeutics Highlight Contrasting Biotech Paths

MRNA

Moderna (MRNA) Climbs +47% in 30 Days on Oncology Momentum

View all blogs related to
#Biotechnology

Interesting Articles

What is Cyber Monday and How Did It Become a Global Phenomenon?

The Future of Trading: Top 5 AI Bots to Manage Market Volatility

The Best Stocks in Microsurgery

DeFi Development Corp. ( $DFDV ) Skyrockets 2279.82% in 2025: What Drove the Surge and What’s Next?

BITF Stock Forecast: 86% Odds of Continued Uptrend Following Bullish 50-Day MA Crossover Above 200-Day MA

View all articles

A.I. Advisor

published General Information

General Information

a developer of biopharmaceuticals

Industry Biotechnology